In response to the availability of the coronavirus vaccine for children ages 5 and older, US Squash has updated its COVID-19 risk-mitigation guidelines and recommendations for accredited competition.
As of January 14, 2022, full vaccination (fourteen days after the second shot of a two-dose vaccine, or after the first shot of a one-dose vaccine) is required for any player competing in a US Squash accredited tournament unless they have been granted a medical or religious exemption.
The updated protocols maintain the recommendation that masks be worn at all levels of play regardless of vaccination status, and maintain the testing requirements set forward in the guidelines most recently updated in October.
Risk-mitigation and safety measures have been developed through consultation with the Medical Advisory Committee, Junior Squash Advisory Panel, and members of the squash community. These protocols continue to be designed to support the desire for many members of the squash community to return to play and competition, while acknowledging that prioritizing the safety of the community requires ongoing adaptation to ensure all reasonable protective measures are in place to do so.
Please refer to the chart below for the summary of guidelines. Full details of the updated protocols is available at: